TG Therapeutics Inc. Stock
TG Therapeutics Inc. Stock
Heavy losses for TG Therapeutics Inc. today as the stock fell by -€1.070 (-6.680%).
With 22 Buy predictions and 4 Sell predictions TG Therapeutics Inc. is one of the favorites of our community.
As a result the target price of 28 € shows a very positive potential of 84.55% compared to the current price of 15.17 € for TG Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for TG Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
TG Therapeutics Inc. | -6.680% | -1.634% | 17.176% | -45.247% | -5.529% | -43.219% | - |
Ardelyx Inc. | 0.340% | -0.416% | 17.913% | 119.146% | 24.360% | 27.221% | - |
Evolus Inc | 5.130% | 4.237% | 16.038% | 36.667% | 35.912% | 72.028% | - |
Salarius Pharmaceuticals Inc. | 7.850% | -5.069% | -1.905% | -64.174% | -25.766% | -98.542% | -99.992% |
Comments
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at HC Wainwright from $45.00 to $49.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at LADENBURG THALM/SH SH from $39.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat